Early results from clinical trials on substances like MDMA and psilocybin have been encouraging. In the middle of what is often regarded as a mental health crisis, many of these initiatives target a few of the most expensive and challenging mental health conditions while they are still happening. Researchers and executives discussed how that might convince health insurers, or “payors,” to jump on board during a Perspective on Psychedelics conference in New York.
During our conversation, my friend posited that cannabis could be a detriment to one's spiritual…
Florida Governor Ron DeSantis recently vetoed a bill that would have severely restricted the sale…
However, a glimmer of hope has emerged from an unlikely source: cannabis. Some individuals with…
Nevertheless, this thought experiment raises a crucial issue that we, as a society, must grapple…
Find the best delta-9 THC gummies of 2024. Leafly reviewed popular delta-9 THC gummies &…
We shall look at the top 10 Twitter (X) handles that offer exclusive information to…